No abstract available
MeSH terms
-
Acute Disease
-
Antibodies / therapeutic use
-
Brain Ischemia / complications*
-
Calcium Channel Blockers / therapeutic use
-
Cardiovascular Agents / therapeutic use*
-
Cell Adhesion Molecules / immunology
-
Clinical Trials as Topic
-
Cytidine Diphosphate Choline / therapeutic use
-
Cytokines / antagonists & inhibitors
-
Drug Therapy, Combination
-
Fibrinolytic Agents / therapeutic use
-
Free Radical Scavengers / therapeutic use
-
Growth Substances / therapeutic use
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
-
N-Methylaspartate / antagonists & inhibitors
-
Neuroprotective Agents / therapeutic use*
-
Nootropic Agents / therapeutic use*
-
Piperidines / therapeutic use
-
Stroke / drug therapy*
-
Stroke / etiology
-
Stroke / mortality
-
Stroke / physiopathology
-
Thiazoles / therapeutic use
-
Thrombolytic Therapy* / methods
-
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid / antagonists & inhibitors
-
gamma-Aminobutyric Acid / drug effects
Substances
-
Antibodies
-
Calcium Channel Blockers
-
Cardiovascular Agents
-
Cell Adhesion Molecules
-
Cytokines
-
Fibrinolytic Agents
-
Free Radical Scavengers
-
Growth Substances
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Neuroprotective Agents
-
Nootropic Agents
-
Piperidines
-
Thiazoles
-
Cytidine Diphosphate Choline
-
gamma-Aminobutyric Acid
-
N-Methylaspartate
-
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
-
lubeluzole